Lanxess Opens Application Development Center in India
German specialty chemicals company Lanxess inaugurated its India Application Development Center (IADC) in Mumbai.
investment
TotalEnergies and Air Liquide to Invest €1 Billion in Dutch Green Hydrogen Projects
TotalEnergies and Air Liquide have signed agreements to develop two projects in the Netherlands, for the production and delivery of some 45,000 t/y of green hydrogen produced using renewable power, generated mostly by the OranjeWind offshore wind farm, developed by TotalEnergies (50%) and RWE (50%).
Fujifilm Ramps up Capacity for Semiconductor Materials in Belgium
Fujifilm plans to invest approximately €25 million to install new production facilities for chemical mechanical planarization (CMP) slurries, which are used in advanced semiconductors, as well as enhance existing facilities for photolithography-related materials at its site in Antwerp, Belgium.
First Companies to Produce at Oman’s Ladayn Polymer Park
Global integrated energy group OQ announced that three companies, representing a combined investment of $42 million, will start operations at Oman’s Ladayn Polymer Park in early 2025.
Repsol Greenlights €800 Million Ecoplant Investment
Spanish energy and petrochemicals group Repsol has approved an investment of more than €800 million to build its Ecoplant in the area of Tarragona, Spain. The first of its kind in Europe, the facility will use urban waste to produce renewable fuels and circular products through gasification, the company said.
Upperton Completes Sterile Manufacturing Facility in UK
UK contract development and manufacturing organization (CDMO) Upperton Pharma Solutions, has completed its new sterile manufacturing facility in Nottingham, UK, expanding its capacity in addition to its existing 50,000-square-foot site at Trent Gateway.
Solvias Opens New Testing Center in North Carolina, US
Solvias, a Switzerland-headquartered provider of chemistry, manufacturing, and control (CMC) analytics, has opened the first phase of its 50,000-square-foot testing center for biologics and cell and gene therapy in Research Triangle Park (RTP), North Carolina, US.
AstraZeneca Plans $570 Million Investment in Canada
To support the move to a larger office facility in the Greater Toronto Area, Ontario, AstraZeneca plans to invest $570 million in Canada, creating more than 700 jobs.
Amgen Opens New Drug Substance Facility in the US
At the end of last week, US biotech Amgen officially opened its newest drug substance facility in Holly Springs, North Carolina, US. The opening day also saw the groundbreaking of a further $1 billion expansion at the North Carolina site, announced less than two months ago.
AkzoNobel Invests €22 Million Streamlining France Operations
AkzoNobel has proposed a €22 million investment to make its Montataire site a flagship for decorative paint production in France.
Carbios Postpones Construction of PET Bio-Recycling Facility in France
French green chemistry company Carbios announced that it is postponing the construction of its PET bio-recycling plant in Longlaville for six to nine months due to delayed funding pending completion of additional financing under satisfactory conditions. The company aims to complete the financing as soon as possible to meet market needs from 2027. Carbios expects to sign several binding commercial contracts in the first half of 2025.
Messer Starts Operation of New Green CO2 Plant in Czechia
German family-owned industrial gases producer Messer has started operations at a new plant for the production of green carbon dioxide (CO2) at its Vrdy site in the Czech Republic.
Toray to Build Pilot Facility for All-Carbon CO2 Separation Membrane in Japan
Japan’s Toray Industries plans to install a pilot facility for its all-carbon carbon dioxide (CO2) separation membrane at its plant in Shiga, Japan.
Clariant Starts New Additives Line in China
Clariant is expanding its Cangzhou production site to manufacture the multifunctional additive Nylostab S-EED.
Novo Nordisk to Build New Production Facility in Odense, Denmark
Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark.
Greensand CCS Project Partners Take Final Investment Decision
Ineos and its partners Harbour Energy and Nordsøfonden have taken the final investment decision (FID) into the first commercial phase ‘Greensand Future’ with storage operations in a depleted oil field in the Danish North Sea set to begin at the end of 2025/early 2026.
Amgen Plans $1 Billion Manufacturing Expansion in North Carolina
In a move to expand its global biomanufacturing network, US biopharma Amgen is planning to invest $1 billion to build a second drug substance manufacturing facility at its US site in Holy Springs, North Carolina. This brings the company's total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550 million commitment.
Lilly Plans $3 Billion Expansion of US Facility in Wisconsin
US drug manufacturer Eli Lilly announced a $3 billion expansion of its US manufacturing facility in Kenosha County, Wisconsin, that the company acquired earlier this year. This investment will extend the company's global parenteral (injectable) product manufacturing network for diabetes, obesity and future medicines across therapeutic areas.
Sanofi to Invest $1 Billion in New Insulin Manufacturing Site in China
Sanofi plans to invest around €1 billion ($1.1 billion) in the construction of a new insulin production facility in Beijing – the company's largest single investment in China to date. This was reported by Reuters and other news agencies.
Givaudan Hikes Encapsulation Technologies Capacity in Mexico
In a move to increase its competitive advantage in Latin America, Swiss flavors, fragrances and active cosmetic ingredients manufacturer Givaudan has inaugurated its newly expanded production facility at the Pedro Escobedo site in Mexico, enhancing the company’s encapsulation technologies.
Air Liquide to Launch New Renewable Hydrogen Production Facility in France
French industrial gases group Air Liquide is launching a renewable hydrogen production project at La Mède, France, to supply TotalEnergies’ biorefinery at that site under a long-term contract. AirLiquide will build, own, and operate the new unit with a capacity of 25,000 t/y, producing hydrogen from recycled biogenic by-products instead of fossil hydrocarbons.
Ube to Increase Capacity for High-Purity Nitric Acid in Japan
Japanese chemical group Ube wants to increase production capacity for high-purity nitric acid at its chemical plant in Ube City, Yamaguchi Prefecture.
Hovione Expands Spray Drying Capacities in the USA and Ireland
Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and Ringaskiddy, Cork, significantly increase the global capacities of the CDMO (contract development and manufacturing organization) for spray drying for pharma applications and improve the sites' capabilities.
ADNOC Launches $80 Billion Investment Vehicle XRG
Abu Dhabi National Oil Company (ADNOC) has launched XRG, an international lower-carbon energy and chemicals investment company, with an enterprise value of over $80 billion.
Samsung Biologics Signs Manufacturing Deal with European Pharmaceutical Company
Samsung Biologics, a global contract development and manufacturing organization (CDMO), recently announced a series of manufacturing deals with a Europe-based pharmaceutical company.
IMCD Expands Pharmaceuticals Technical Centre and Wins Laura Marshall Award
IMCD Group, a global distribution partner and formulator of specialty chemicals and ingredients, recently announced the expansion of its Pharmaceuticals Technical Centre in Jakarta, Indonesia. This facility will serve as the hub for pharmaceutical development and innovation across Southeast Asia, Australia, and New Zealand.
Avantor Opens New US Innovation Center in Bridgewater
Avantor has opened its latest Innovation Center in Bridgewater, New Jersey, US, “to support the growing demands for monoclonal antibodies, cell and gene therapy and mRNA workflows.” The new center is now part of the company’s network of 13 global research and innovation centers.
Siegfried Opens New Drug Substances R&D Center in Evionnaz
Zofingen, Switzerland-based contract development and manufacturing organization (CDMO) Siegfried inaugurated its new global research and development (R&D) center for drug substances at its site in Evionnaz, Switzerland. The 4,500 m2 center houses chemical and analytical facilities, laboratories, and technologies such as flow chemistry, advanced distillation and process analytical technology, as well as new office space.
Ambiopharm Breaks Ground on $28 Million Expansion
Ambiopharm, a US-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2) capacity expansion project at its Shanghai manufacturing site. This $28 million (€26.6 million) project reflects the company’s commitment to serving growing global demand and confidence in China’s vital role in the global pharmaceutical supply chain.
AstraZeneca to Invest $3.5 Billion in the US
Anglo-Swedish drugmaker AstraZeneca plans to invest $3.5 billion in the US to expand the company’s research and manufacturing footprint by the end of 2026.
Nouryon Completes Expansion for Organic Peroxides in China
Dutch specialty chemicals producer Nouryon has completed the capacity expansion for organic peroxides at its manufacturing facility in Ningbo, China. The expansion doubled production capacity to 6,000 tons of organic peroxide products each, which are sold under the Perkadox 14 and Trigonox 101 brands.
Lonza to Expand Bioconjugation in Visp, Switzerland
Lonza, a global contract development and manufacturing organization (CDMO) for the pharmaceutical, biotech, and nutraceutical markets, announced today that it will invest in additional bioconjugation capabilities in Visp, Switzerland.
Evonik to Expand Specialty Amine Production in Nanjing, China
German specialty chemicals group Evonik broke ground on its plant expansion for specialty amines at its site Nanjing, China, on Nov. 8. Construction work is expected to be completed in 2026.
SABIC Opens Multi-Million-Dollar Resin Manufacturing Facility in Singapore
SABIC recently announced the official launch of its new US$170 (€157.7) million ultem resin manufacturing facility in Singapore, marking the company’s first advanced specialty chemical manufacturing facility in the region producing the high-performance thermoplastic, ultem resin.
Ardena Expands European Bioanalytical Capabilities
Belgium-headquartered pharmaceutical contract development and manufacturing organization (CDMO) Ardena announced plans to expand its bioanalytical services in the Netherlands. As part of the investment, the company plans to establish a new bioanalytical laboratory at its Pivot Park facility in Oss, as well as additional capacity and new GLP capabilities at its bioanalytical center of excellence in Assen.
Orion S.A.
Merck & Co
Bayer AG
Avantor
Saltigo GmbH
Enzene Biosciences Ltd
Optex Innovation Center
Samsung Biologics
Henkel AG & Co. KGaA
BASF SE
Novartis International AG
Thyssenkrupp Nucera AG & Co. KGaA
Elixir Group DOO
Carbios
Mitsubishi Chemical Europe GmbH
Novo Nordisk Pharmatech A/S
CordenPharma International
Lenzing AG
IMCD Group B.V.
Aenova Holding GmbH
Gilead Sciences, Inc.
Sharp Services
LyondellBasell
Sika AG
Carbon Waters
Ineos
Symrise
Clariant International Ltd
Upperton Pharma Solutions
Ferrostaal
AkzoNobel
Roche Group
Flamma Group
Honeywell International Inc.
Solvay
Atome
Aurigene Pharmaceutical Services Ltd.
AstraZeneca
Aragen Life Sciences Ltd.
Evonik Industries AG
Nova Chemicals
Solenis LLC
Dow Chemical Company
Aditya Birla Group
Nippon Shokubai Co., Ltd.
Trinseo LLC
Olon S.p.A.
Ice Pharma
Lonza AG
Sanner GmbH